Phillip Walker

560 total citations
56 papers, 328 citations indexed

About

Phillip Walker is a scholar working on Pulmonary and Respiratory Medicine, Oncology and Cancer Research. According to data from OpenAlex, Phillip Walker has authored 56 papers receiving a total of 328 indexed citations (citations by other indexed papers that have themselves been cited), including 30 papers in Pulmonary and Respiratory Medicine, 20 papers in Oncology and 14 papers in Cancer Research. Recurrent topics in Phillip Walker's work include Cancer Genomics and Diagnostics (12 papers), Ferroptosis and cancer prognosis (9 papers) and Lung Cancer Treatments and Mutations (9 papers). Phillip Walker is often cited by papers focused on Cancer Genomics and Diagnostics (12 papers), Ferroptosis and cancer prognosis (9 papers) and Lung Cancer Treatments and Mutations (9 papers). Phillip Walker collaborates with scholars based in United States, Australia and Austria. Phillip Walker's co-authors include José A. Díaz-Buxó, Jonathan Golledge, W. Patrick Burgess, Reinhold Müller, Frank Quigley, Joseph V. Moxon, Ramesh Velu, Simon Green, Christopher D. Askew and Bruce C. Robertson and has published in prestigious journals such as Journal of Clinical Oncology, Cancer Research and Clinical Cancer Research.

In The Last Decade

Phillip Walker

49 papers receiving 308 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Phillip Walker United States 11 127 126 115 55 38 56 328
O Wagner Austria 8 118 0.9× 61 0.5× 60 0.5× 31 0.6× 15 0.4× 20 347
Kazushi Nakao Japan 14 103 0.8× 236 1.9× 48 0.4× 22 0.4× 38 1.0× 24 465
Robert Dunlay United States 10 75 0.6× 264 2.1× 140 1.2× 56 1.0× 34 0.9× 12 480
Kanji Shishido Japan 12 101 0.8× 216 1.7× 38 0.3× 25 0.5× 12 0.3× 26 360
A. Bouman Netherlands 12 62 0.5× 79 0.6× 89 0.8× 58 1.1× 13 0.3× 24 321
Takashin Nakayama Japan 10 63 0.5× 108 0.9× 54 0.5× 25 0.5× 12 0.3× 53 277
Myriam Farah Canada 10 141 1.1× 167 1.3× 118 1.0× 17 0.3× 21 0.6× 17 394
Fumiko Sakata Japan 12 77 0.6× 177 1.4× 44 0.4× 19 0.3× 21 0.6× 19 309
Carlo Alberto Ricciardi Italy 10 120 0.9× 223 1.8× 162 1.4× 19 0.3× 174 4.6× 19 547

Countries citing papers authored by Phillip Walker

Since Specialization
Citations

This map shows the geographic impact of Phillip Walker's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Phillip Walker with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Phillip Walker more than expected).

Fields of papers citing papers by Phillip Walker

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Phillip Walker. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Phillip Walker. The network helps show where Phillip Walker may publish in the future.

Co-authorship network of co-authors of Phillip Walker

This figure shows the co-authorship network connecting the top 25 collaborators of Phillip Walker. A scholar is included among the top collaborators of Phillip Walker based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Phillip Walker. Phillip Walker is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Choucair, Khalil, Andrew Elliott, Matthew J. Oberley, et al.. (2025). Molecular and immune landscape of tumours in geriatric patients with non-small cell lung cancer, melanoma and renal cell carcinoma. PubMed. 4(1). e000551–e000551.
2.
Reuss, Joshua E., Nishant Gandhi, Phillip Walker, et al.. (2025). Comprehensive molecular profiling of squamous non-small cell lung cancer reveals high incidence of actionable genomic alterations among patients with no history of smoking. Lung Cancer. 200. 108101–108101. 1 indexed citations
3.
Walker, Phillip, Joanne Xiu, Emil Lou, et al.. (2024). Molecular Landscape and Clinical Implication of CCNE1- amplified Esophagogastric Cancer. Cancer Research Communications. 4(6). 1399–1409. 4 indexed citations
4.
Marks, Jennifer A., Nishant Gandhi, Balázs Halmos, et al.. (2024). Molecular profiling METex14+ non-small cell lung cancer (NSCLC): Impact of histology. Lung Cancer. 196. 107935–107935. 2 indexed citations
5.
Florou, Vaia, Andrew Elliott, Matthew H. Bailey, et al.. (2023). Comparative Genomic Analysis of Pancreatic Acinar Cell Carcinoma (PACC) and Pancreatic Ductal Adenocarcinoma (PDAC) Unveils New Actionable Genomic Aberrations in PACC. Clinical Cancer Research. 29(17). 3408–3417. 10 indexed citations
6.
Cavalcante, Ludimila, Sachin Kumar Deshmukh, Jennifer R. Ribeiro, et al.. (2023). Opposing Roles of SPOP Mutations in Human Prostate and Endometrial Cancers. JCO Precision Oncology. 7(7). e2300088–e2300088. 4 indexed citations
7.
Reuss, Joshua E., Nishant Gandhi, Phillip Walker, et al.. (2023). Spectrum of acquired KRAS mutations in driver mutation-positive non-small cell lung cancer.. Journal of Clinical Oncology. 41(16_suppl). 9069–9069.
8.
Faber, Erik B., Phillip Walker, Peter J. Hosein, et al.. (2023). Genomic profiling of rare undifferentiated sarcomatoid subtypes of pancreatic carcinomas for potential response to immunotherapy.. Journal of Clinical Oncology. 41(4_suppl). 741–741. 1 indexed citations
9.
Marks, Jennifer A., Nishant Gandhi, Balázs Halmos, et al.. (2023). Updated molecular analysis of MET exon 14skippingmutations (METex14) in non-small cell lung cancer (NSCLC).. Journal of Clinical Oncology. 41(16_suppl). 9095–9095. 2 indexed citations
10.
Moy, Ryan H., Sharon Wu, Joanne Xiu, et al.. (2023). Molecular landscape and clinical implication of CCNE1-amplified esophagogastric cancer.. Journal of Clinical Oncology. 41(4_suppl). 440–440.
11.
Reuss, Joshua E., Nishant Gandhi, Phillip Walker, et al.. (2023). 1399P Tumor-immune microenvironment analysis of de novo and acquired KRAS-mutated non-small cell lung cancer. Annals of Oncology. 34. S800–S801. 1 indexed citations
12.
Baca, Yasmine, Jennifer R. Ribeiro, Phillip Walker, et al.. (2023). Multiomic Characterization Reveals a Distinct Molecular Landscape in Young-Onset Pancreatic Cancer. JCO Precision Oncology. 7 indexed citations
13.
Kim, So Yeon, Jun‐Jie Yin, Phillip Walker, et al.. (2022). Characterization of MET Exon 14 Skipping Alterations (in NSCLC) and Identification of Potential Therapeutic Targets Using Whole Transcriptome Sequencing. JTO Clinical and Research Reports. 3(9). 100381–100381. 13 indexed citations
14.
Marks, Jennifer A., Jun‐Jie Yin, Balázs Halmos, et al.. (2022). Analysis of MET exon 14skippingmutations in non–small cell lung cancer (NSCLC) by histology and specific mutation.. Journal of Clinical Oncology. 40(16_suppl). 9119–9119.
15.
Zhong, Jim, et al.. (2020). Imaging post liver transplantation part I: vascular complications. Clinical Radiology. 75(11). 845–853. 8 indexed citations
16.
Golledge, Jonathan, Frank Quigley, Ramesh Velu, Phillip Walker, & Joseph V. Moxon. (2014). Association of impaired fasting glucose, diabetes and their management with the presentation and outcome of peripheral artery disease: a cohort study. Cardiovascular Diabetology. 13(1). 147–147. 34 indexed citations
17.
18.
Campbell, Gordon, et al.. (2005). Vascular engineering for bypass surgery. Expert Review of Cardiovascular Therapy. 3(4). 659–665. 3 indexed citations
19.
Green, Simon, et al.. (2001). Effect of propionyl-L-carnitine on exercise performance in peripheral arterial disease. Medicine & Science in Sports & Exercise. 33(9). 1415–1422. 27 indexed citations
20.
Stephens, Frederick O., Paul Crea, & Phillip Walker. (1986). The implantable "Infusaid" infusion pump. The Sydney experience using 5-fluorouracil.. PubMed. 144(2). 74–7. 4 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by O Wagner Breakdown of academic impact, for papers by Kazushi Nakao Breakdown of academic impact, for papers by Robert Dunlay Breakdown of academic impact, for papers by Kanji Shishido Breakdown of academic impact, for papers by A. Bouman Breakdown of academic impact, for papers by Takashin Nakayama Breakdown of academic impact, for papers by Myriam Farah Breakdown of academic impact, for papers by Fumiko Sakata Breakdown of academic impact, for papers by Carlo Alberto Ricciardi
Rankless by CCL
2026